Tine Thurison Sørensen - Publications

I.K. Lund, M. Illemann, T. Thurison, I.J. Christensen, and G. Høyer-Hansen. uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy. Review, Current Drug Targets, The urokinase plasminogen activation system in pathology: use in prognosis and therapy Jun. 27 2011.

T. Thurison, A.F. Lomholt, M.G. Rasch, I.K. Lund, H.J. Nielsen, I.J. Christensen, G. Høyer-Hansen. A new assay for the measurement of the liberated Domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancer. Clin. Chem. 2010, 56:1636-1640.

F.J. Olson, T. Thurison, M. Ryndel, G. Høyer-Hansen, and B. Fagerberg. Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability. Clin. Biochem. 2010, 43:124-130.

T. Thurison, I. K. Lund, M. Illemann, G. Høyer-Hansen and I.J. Christensen. Plasminogen activators and their regulators as biomarkers in cancer. Manuscript accepted for publication in "Martix proteases in health and disease" 2011, Wiley-VCH STM-Books, Germany.